Visit | AyuFlex1 (n = 56) | AyuFlex2 (n = 66) | Placebo (n = 50) | p value | ||||
---|---|---|---|---|---|---|---|---|
Overalla | AF1 + AF2 vs PBO | AF1 vs PBO | AF2 vs PBO | AF1 vs AF2 | ||||
Overalla | 0.053 | 0.046 | 0.043 | 0.105 | 0.165 | |||
0 | 35.3 (±22.9) | 38.2 (±28.0) | 31.1 (±22.8) | |||||
14 | 32.8 (±22.6) | 31.3 (±25.8) | 33.2 (±21.5) | 0.073 | 0.227 | 0.036 | 0.332 | |
42 | 27.8 (±21.7) | 31.4 (±24.5) | 32.9 (±24.3) | 0.089 | 0.059 | 0.263 | 0.537 | |
84 | 22.1 (±19.5) | 24.7 (±23.8) | 33.4 (±25.1) | 0.001 | 0.001 | 0.005 | 0.651 | |
Changes to Measures of Discomfort with Activity or Exerciseb | ||||||||
−13.2 (±24.4) | −13.5 (±28.7) | 2.2 (±21.6) | 0.002 | <0.001 | 0.002 | 0.001 | 0.956 |